Recruiting Retinitis Pigmentosa Studies in Omaha
About Retinitis Pigmentosa Clinical Trials in Omaha
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 3 retinitis pigmentosa clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 342 participants. Research is being sponsored by Olympus Corporation of the Americas, Radiopharm Theranostics, Ltd, Monte Rosa Therapeutics, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Omaha — FAQ
Are there retinitis pigmentosa clinical trials in Omaha?
Yes, there are 3 retinitis pigmentosa clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Omaha?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.
Are clinical trials in Omaha free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 3 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated October 16, 2026 from ClinicalTrials.gov